Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers
- PMID: 25294805
- PMCID: PMC4253439
- DOI: 10.18632/oncotarget.2430
Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers
Abstract
Upregulated expression and activation of human telomerase reverse transcriptase (hTERT) is a hallmarker of lung tumorigenesis. However, the mechanism underlying the aberrant hTERT activity in lung cancer cells remains poorly understood. In this study, we found the transcriptional co-activator CBP as a new hTERT promoter-binding protein that regulated hTERT expression and tumor growth in lung adenocarcinoma cells using a biotin-streptavidin-bead pulldown technique. Chromatin immunoprecipitation assay verified the immortalized cell and tumor cell-specific binding of CBP on hTERT promoter. Overexpression of exogenous CBP upregulated the expression of the hTERT promoter-driven luciferase and endogenous hTERT protein in lung cancer cells. Conversely, inhibition of CBP by CBP-specific siRNA or its chemical inhibitor repressed the expression of hTERT promoter-driven luciferase and endogenous hTERT protein as well as telomerase activity. Moreover, inhibition of CBP expression or activity also significantly reduced the proliferation of lung cancer cells in vitro and tumor growth in an xenograft mouse model in vivo. Immunohistochemical analysis of tissue microarrays of lung cancers revealed a positive correlation between CBP and hTERT. Importantly, the patients with high CBP and hTERT expression had a significantly shorter overall survival. Furthermore, CBP was found to interact with and acetylate transactivator Sp1 in lung cancer cells. Inhibition of CBP by CBP-specific siRNA or its chemical inhibitor significantly inhibited Sp1 acetylation and its binding to the hTERT promoter. Collectively, our results indicate that CBP contributes to the upregulation of hTERT expression and tumor growth, and overexpression of CBP predicts poor prognosis in human lung cancers.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth.Oncotarget. 2015 Sep 29;6(29):27130-45. doi: 10.18632/oncotarget.4825. Oncotarget. 2015. PMID: 26318425 Free PMC article.
-
CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.Mol Oncol. 2016 Feb;10(2):317-29. doi: 10.1016/j.molonc.2015.10.015. Epub 2015 Nov 5. Mol Oncol. 2016. PMID: 26628108 Free PMC article.
-
CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.Mol Oncol. 2014 May;8(3):704-16. doi: 10.1016/j.molonc.2014.02.001. Epub 2014 Feb 14. Mol Oncol. 2014. PMID: 24618080 Free PMC article.
-
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.Cancer Sci. 2008 Aug;99(8):1528-38. doi: 10.1111/j.1349-7006.2008.00878.x. Cancer Sci. 2008. PMID: 18754863 Free PMC article. Review.
-
Overexpression of APC11 predicts worse survival in lung adenocarcinoma [Corrigendum].Onco Targets Ther. 2019 May 2;12:3361-3362. doi: 10.2147/OTT.S212589. eCollection 2019. Onco Targets Ther. 2019. PMID: 31118687 Free PMC article. Review. No abstract available.
Cited by
-
Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells.Oncotarget. 2016 Jul 12;7(28):43162-43176. doi: 10.18632/oncotarget.9012. Oncotarget. 2016. PMID: 27281610 Free PMC article.
-
Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.Cell Death Dis. 2017 Jul 27;8(7):e2961. doi: 10.1038/cddis.2017.339. Cell Death Dis. 2017. PMID: 28749462 Free PMC article.
-
YBX1 regulates tumor growth via CDC25a pathway in human lung adenocarcinoma.Oncotarget. 2016 Dec 13;7(50):82139-82157. doi: 10.18632/oncotarget.10080. Oncotarget. 2016. PMID: 27384875 Free PMC article.
-
KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.Cell Death Dis. 2017 Jul 20;8(7):e2940. doi: 10.1038/cddis.2017.285. Cell Death Dis. 2017. PMID: 28726783 Free PMC article.
-
Novel genetic variants in HDAC2 and PPARGC1A of the CREB-binding protein pathway predict survival of non-small-cell lung cancer.Mol Carcinog. 2020 Jan;59(1):104-115. doi: 10.1002/mc.23132. Epub 2019 Nov 12. Mol Carcinog. 2020. PMID: 31713888 Free PMC article.
References
-
- Tomas-Loba A, Flores I, Fernandez-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borras C, Matheu A, Klatt P, Flores JM, Vina J, Serrano M, Blasco MA. Telomerase reverse transcriptase delays aging in cancer-resistant mice. Cell. 2008;135(4):609–622. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical